|
Market Closed -
OTC Markets
23:51:57 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0122 USD | -17.09% |
|
-27.22% | -97.25% |
Company Valuation: ProPhase Labs, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 106.5 | 111 | 156.8 | 81.56 | 18.08 | 2.067 |
| Change | - | 4.23% | 41.18% | -47.97% | -77.84% | -88.57% |
| Enterprise Value (EV) 1 | 112.8 | 108.7 | 146.3 | 98.21 | 41.97 | 10.59 |
| Change | - | -3.65% | 34.61% | -32.86% | -57.26% | -74.76% |
| P/E | -50.1x | 18.1x | 9.41x | -4.61x | -0.29x | -0.26x |
| PBR | 10.1x | 1.89x | 2.45x | 1.65x | 3.08x | 1.14x |
| PEG | - | -0x | 0x | 0x | -0x | 0x |
| Capitalization / Revenue | 7.34x | 1.4x | 1.28x | 1.84x | 2.67x | 0.48x |
| EV / Revenue | 7.77x | 1.37x | 1.19x | 2.21x | 6.2x | 2.44x |
| EV / EBITDA | -31.9x | 8.34x | 5.17x | -6.4x | -1.29x | -0.8x |
| EV / EBIT | -28.3x | 11.1x | 6.2x | -4.54x | -1.09x | -0.59x |
| EV / FCF | 30.2x | -5.49x | 6.97x | -23.1x | 8.37x | 0.25x |
| FCF Yield | 3.31% | -18.2% | 14.3% | -4.33% | 12% | 406% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.833 | 3.954 | 10.24 | -9.8 | -26.08 | -1.737 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 14.51 | 79.04 | 122.6 | 44.38 | 6.77 | 4.345 |
| EBITDA 1 | -3.536 | 13.04 | 28.31 | -15.34 | -32.44 | -13.22 |
| EBIT 1 | -3.985 | 9.801 | 23.6 | -21.61 | -38.63 | -18.05 |
| Net income 1 | -2.125 | 6.273 | 18.46 | -16.78 | -53.36 | -14.74 |
| Net Debt 1 | 6.267 | -2.362 | -10.48 | 16.64 | 23.9 | 8.528 |
| Reference price 2 | 91.8000 | 71.7000 | 96.3000 | 45.2000 | 7.5710 | 0.4475 |
| Nbr of stocks (in thousands) | 1,160 | 1,549 | 1,628 | 1,805 | 2,387 | 4,618 |
| Announcement Date | 31/03/21 | 31/03/22 | 29/03/23 | 29/03/24 | 01/04/25 | 01/06/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 191K | |
| -271.17x | 17.93x | -322.05x | -.--% | 53.25B | |
| 23.02x | 2.11x | 11.95x | 0.91% | 26.01B | |
| 15.69x | 1.25x | 7.08x | 5.58% | 6.76B | |
| 1085.71x | - | - | - | 5.98B | |
| 51.26x | 9.45x | 32.54x | 0.98% | 3.3B | |
| -30.13x | - | - | - | 3.02B | |
| -67.21x | - | - | -.--% | 2.56B | |
| 15.58x | 1.62x | 6.34x | 5.11% | 2.25B | |
| 31.66x | 1.65x | 12.36x | 1.42% | 1.91B | |
| Average | 94.93x | 5.67x | -41.96x | 2% | 10.5B | |
| Weighted average by Cap. | -68.91x | 11.30x | -178.05x | 0.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PRPH Stock
- Valuation ProPhase Labs, Inc.
Select your edition
All financial news and data tailored to specific country editions
